Business Segments MicroPort Scientific Corporation
Equities
853
KYG608371046
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.580 HKD | +0.44% | -0.43% | -45.61% |
08-30 | MicroPort Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
08-23 | MicroPort CardioFlow Medtech to Buy Industrial Site from MicroPort Medical | MT |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Orthopedics Devices Business | 232M | 202M | 216M | 225M | 238M | |||||
Total Assets | 421M | 450M | 491M | 489M | 529M | |||||
Interest Expense | -5.09M | -5.02M | -3.25M | -5.98M | -10.78M | |||||
Income Tax Expense | 976K | 1.76M | 1.48M | - | - | |||||
CAPEX | -38.05M | -26.56M | -46.46M | -54.6M | - | |||||
D&A | 26.54M | 27.75M | 25.41M | 26.92M | 29.02M | |||||
Net Income | -30.79M | -61.43M | -26.22M | -88.55M | -79.85M | |||||
Cardiac Rhythm Management (CRM) Business | 209M | 180M | 220M | 205M | 207M | |||||
Total Assets | 341M | 393M | 436M | 471M | 395M | |||||
Interest Expense | -5.51M | -6.41M | -15.45M | -21.98M | -26.09M | |||||
Income Tax Expense | -1.22M | 1.74M | 2.99M | - | - | |||||
CAPEX | -13.08M | -9.92M | -31.14M | -6.61M | - | |||||
D&A | 13.26M | 12.18M | 18.09M | 14.97M | 16.46M | |||||
Net Income | -54.84M | -47.24M | -84.89M | -101M | -103M | |||||
Endovascular and Peripheral Vascular Devices Business | 48.53M | 68.49M | 106M | 133M | 168M | |||||
Total Assets | 168M | 214M | 275M | 287M | 599M | |||||
Interest Expense | -159K | -174K | -275K | -308K | -209K | |||||
Income Tax Expense | 3.57M | 5.89M | 8.29M | - | - | |||||
CAPEX | -3.89M | -3.67M | -17.64M | -66.88M | - | |||||
D&A | 2.01M | 2.96M | 3.68M | 6.66M | 7.16M | |||||
Net Income | 20.46M | 30.77M | 47.76M | 52.42M | 69.05M | |||||
Neurovascular Devices Business | 27.63M | 32.93M | 59.05M | 80.2M | 94.17M | |||||
Total Assets | 51M | 124M | 210M | 261M | 277M | |||||
Interest Expense | -242K | -563K | -7.01M | -15.21M | -490K | |||||
Income Tax Expense | 1.12M | 555K | 1.23M | - | - | |||||
CAPEX | -9.67M | -7.56M | -55.31M | -6.38M | - | |||||
D&A | 1.59M | 2.59M | 5M | 8.51M | 8.3M | |||||
Net Income | 5.05M | 5.04M | 3.56M | -4.32M | 19.09M | |||||
Others | 3.42M | 814K | 1.6M | 21.77M | 31.54M | |||||
Total Assets | 47.32M | 80.01M | 446M | 560M | 613M | |||||
Interest Expense | -55K | - | -1.06M | -2.79M | -4.12M | |||||
Income Tax Expense | - | - | -93K | - | - | |||||
CAPEX | -236K | -10.97M | -126M | -72.51M | - | |||||
D&A | 208K | 201K | 2.71M | 14.75M | 14.13M | |||||
Net Income | -11.88M | -18.46M | -56.14M | -77.8M | -102M | |||||
Cardiovascular Devices Business | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Electrophysiology Devices Business | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Diabetes and Endocrinal Devices Business | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Medical Instruments | ||||||||||
Cardiovascular Devices Business (Excluding CRM & Surgical Robot Device & Heart Valve Business) | 265M | 145M | 140M | 147M | 159M | |||||
Total Assets | 507M | 750M | 611M | 566M | 519M | |||||
Interest Expense | -212K | -900K | -877K | -2.49M | -3.33M | |||||
Income Tax Expense | 18.87M | -767K | -1.96M | - | - | |||||
CAPEX | -45.92M | -48.02M | -214M | -17.72M | - | |||||
D&A | 14.91M | 20.76M | 15.63M | 22.27M | 21.48M | |||||
Net Income | 111M | 18.86M | 9.42M | -7.41M | 4.31M | |||||
Heart Valve Business | 3.12M | 15.2M | 31.32M | 37.02M | 47.52M | |||||
Total Assets | 76.64M | 169M | 524M | 433M | 364M | |||||
Interest Expense | -1.39M | -20.82M | -3M | -768K | -555K | |||||
Income Tax Expense | - | - | 95K | - | - | |||||
CAPEX | -8.68M | -7.15M | -65.58M | -22.76M | - | |||||
D&A | 1.64M | 3.11M | 4.82M | 15.01M | 10.09M | |||||
Net Income | -20.96M | -57.87M | -28.5M | -66.33M | -66.83M | |||||
Medical Equipment | ||||||||||
Surgical Robot Devices Business | - | - | 329K | 3.09M | 14.81M | |||||
Total Assets | 15.81M | 262M | 437M | 277M | 201M | |||||
Interest Expense | - | -11K | -821K | -1.65M | -2.61M | |||||
CAPEX | -2.54M | -19.48M | -61.3M | -48.07M | - | |||||
D&A | 187K | 361K | 4.97M | 16.03M | 15.8M | |||||
Net Income | -6.74M | -25.33M | -97.72M | -169M | -145M | |||||
Surgical Devices Business | 4.7M | 4.63M | 4.73M | 4.51M | 7.76M | |||||
Total Assets | 33.71M | 23.79M | 210M | 213M | 98.46M | |||||
Interest Expense | -6K | - | -330K | -737K | -740K | |||||
Income Tax Expense | 125K | 1K | - | - | - | |||||
CAPEX | -2.29M | -2.01M | -176M | -10.78M | - | |||||
D&A | 842K | 897K | 2.16M | 7.26M | 9.1M | |||||
Net Income | -5.19M | -3.35M | -11.48M | -30.36M | -130M | |||||
Total Assets | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Total Assets | 126K | 1.39M | 59.96M | 49.02M | 56.44M | |||||
Total Assets | 20.85M | 44.78M | 530M | 243M | 49.39M | |||||
Total Assets | -89.52M | -74.47M | -93.88M | -119M | -88.97M | |||||
Net Income | -24.44M | -23.12M | -42.36M | -41.64M | -46.82M | |||||
Net Income | 1.38M | -509K | -2.44M | -2.9M | -3.72M | |||||
Net Income | - | - | - | - | - | |||||
Net Income | 55.84M | - | 8.22M | 7.11M | 2.84M | |||||
Net Income | - | - | - | - | - | |||||
Net Income | -2.99M | -35.28M | -6.9M | -6.22M | -4.24M | |||||
Net Income | -7.26M | -5.41M | -54.78M | -35.99M | -12.59M | |||||
Total Assets | - | 1.66M | - | - | - | |||||
Total Assets | 5.53M | 3.61M | 77.79M | 102M | 71.22M | |||||
Total Assets | - | 26.7M | - | - | - | |||||
Net Income | - | - | -8.83M | -16.25M | -35.88M | |||||
Total Assets | - | - | 166M | 161M | 144M | |||||
Inter-Segment Revenue | - | - | - | -16.2M | -17.57M | |||||
Total Assets | - | - | - | - | 106M | |||||
Net Income | - | - | - | - | -14.27M |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
The People's Republic of China (The PRC) | 361M | 289M | 357M | 406M | 493M | |||||
Total Assets | 458M | 540M | 1.32B | 1.38B | 1.34B | |||||
Europe | 242M | 207M | 242M | 247M | 254M | |||||
Total Assets | 177M | 203M | 271M | 296M | 249M | |||||
North America | 104M | 87.8M | 94.98M | 96.46M | 99.93M | |||||
Total Assets | 121M | 107M | 179M | 186M | 140M | |||||
Asia (Excluding The PRC) | 56.34M | 57.2M | 64.36M | 64.09M | 71.42M | |||||
Total Assets | 13.97M | 27.35M | 66.24M | 50.37M | 35.06M | |||||
South America | 13.78M | 5.75M | 9.7M | 12.06M | 22.81M | |||||
Total Assets | 4.22M | 2.24M | 3.27M | 1.52M | 837K | |||||
Others | 16.41M | 2.08M | 10.83M | 15.73M | 10.19M | |||||
Total Assets | - | 396K | 335K | 271K | 195K |
- Stock Market
- Equities
- 853 Stock
- Financials MicroPort Scientific Corporation
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition